awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33218518-34EB0DA7-2646-406E-BF99-C9F10C42A1C6
Q33218518-34EB0DA7-2646-406E-BF99-C9F10C42A1C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33218518-34EB0DA7-2646-406E-BF99-C9F10C42A1C6
The application of RAGE and GECKO in cell-based target discovery screens.
P2860
Q33218518-34EB0DA7-2646-406E-BF99-C9F10C42A1C6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33218518-34EB0DA7-2646-406E-BF99-C9F10C42A1C6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
caa0f59c0f029035dbb771d5856c1a1dd7904ced
P2860
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.